{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:17Z","timestamp":1787032817326,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,24]]},"DOI":"10.7759\/cureus.111418","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:21:29Z","timestamp":1782303689000},"source":"Crossref","is-referenced-by-count":1,"title":["Cefepime-Induced Delirium in a Patient With Chronic Kidney Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Helena","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo M","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. APA Press, Washington, DC; 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-021-00268-1","article-title":"Delirium associations with antibiotics: a pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS)","volume":"9","author":"Teng C","year":"2022","unstructured":"Teng C, Frei CR. Delirium associations with antibiotics: a pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS). Drugs Real World Outcomes. 2022, 9:23-9. 10.1007\/s40801-021-00268-1","journal-title":"Drugs Real World Outcomes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0578-2","article-title":"Neurological adverse effects attributable to \u03b2-lactam antibiotics: a literature review","volume":"40","author":"Deshayes S","year":"2017","unstructured":"Deshayes S, Coquerel A, Verdon R. Neurological adverse effects attributable to \u03b2-lactam antibiotics: a literature review. Drug Saf. 2017, 40:1171-98. 10.1007\/s40264-017-0578-2","journal-title":"Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.6.6.805","article-title":"Cefepime: a reappraisal in an era of increasing antimicrobial resistance","volume":"6","author":"Endimiani A","year":"2008","unstructured":"Endimiani A, Perez F, Bonomo RA. Cefepime: a reappraisal in an era of increasing antimicrobial resistance. Expert Rev Anti Infect Ther. 2008, 6:805-24. 10.1586\/14787210.6.6.805","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.9.2265","article-title":"Cefepime-related neurotoxicity in a haemodialysis patient","volume":"14","author":"Wong KM","year":"1999","unstructured":"Wong KM, Chan WK, Chan YH, Li CS. Cefepime-related neurotoxicity in a haemodialysis patient. Nephrol Dial Transplant. 1999, 14:2265-6. 10.1093\/ndt\/14.9.2265","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne LE","year":"2017","unstructured":"Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL. Cefepime-induced neurotoxicity: a systematic review. Crit Care. 2017, 21:276. 10.1186\/s13054-017-1856-1","journal-title":"Crit Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01595-08","article-title":"High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function","volume":"54","author":"Lamoth F","year":"2010","unstructured":"Lamoth F, Buclin T, Pascual A, et al.. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrob Agents Chemother. 2010, 54:4360-7. 10.1128\/AAC.01595-08","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","article-title":"[Non-convulsive status epilepticus secondary to adjusted cefepime doses in patients with chronic renal failure]","volume":"20","author":"Saurina A","year":"2000","unstructured":"Saurina A, Vera M, Pou M, L\u00f3pez Pedret J, Darnell A, Campistol JM, Cases A. [Non-convulsive status epilepticus secondary to adjusted cefepime doses in patients with chronic renal failure]. Nefrologia. 2000, 20:554-8.","journal-title":"Nefrologia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(03)00188-6","article-title":"Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins","volume":"45","author":"Sugimoto M","year":"2003","unstructured":"Sugimoto M, Uchida I, Mashimo T, et al.. Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology. 2003, 45:304-14. 10.1016\/S0028-3908(03)00188-6","journal-title":"Neuropharmacology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx170","article-title":"Characterizing cefepime neurotoxicity: a systematic review","volume":"4","author":"Appa AA","year":"2017","unstructured":"Appa AA, Jain R, Rakita RM, Hakimian S, Pottinger PS. Characterizing cefepime neurotoxicity: a systematic review. Open Forum Infect Dis. 2017, 4:ofx170. 10.1093\/ofid\/ofx170","journal-title":"Open Forum Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15505","article-title":"Cefepime-induced delirium","volume":"13","author":"Somoza-Cano FJ","year":"2021","unstructured":"Somoza-Cano FJ, Al Armashi AR, Weiland A, Chakhachiro D, Ravakhah K. Cefepime-induced delirium. Cureus. 2021, 13:e15505. 10.7759\/cureus.15505","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506043-cefepime-induced-delirium-in-a-patient-with-chronic-kidney-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:21:30Z","timestamp":1782303690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506043-cefepime-induced-delirium-in-a-patient-with-chronic-kidney-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.111418","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}